Showing 14,001 - 14,020 results of 135,317 for search '(( 2 we decrease ) OR ( 5 ((((ng decrease) OR (a decrease))) OR (mean decrease)) ))', query time: 2.10s Refine Results
  1. 14001
  2. 14002

    Hyperlipidemia-Associated Renal Damage Decreases Klotho Expression in Kidneys from ApoE Knockout Mice by Cristina Sastre (503532)

    Published 2013
    “…</p><p>Methods</p><p>We evaluated whether hyperlipidemia modulates Klotho expression in kidneys from C57BL/6 and hyperlipidemic apolipoprotein E knockout (ApoE KO) mice fed with a normal chow diet (ND) or a Western-type high cholesterol-fat diet (HC) for 5 to 10 weeks, respectively.…”
  3. 14003

    Secreted Herpes Simplex Virus-2 Glycoprotein G Modifies NGF-TrkA Signaling to Attract Free Nerve Endings to the Site of Infection by Jorge Rubén Cabrera (685511)

    Published 2015
    “…SgG2 alters TrkA recruitment to lipid rafts and decreases TrkA internalization. …”
  4. 14004

    Three New Phases in the K/Cu/Th/S System:  KCuThS<sub>3</sub>, K<sub>2</sub>Cu<sub>2</sub>ThS<sub>4</sub>, and K<sub>3</sub>Cu<sub>3</sub>Th<sub>2</sub>S<sub>7</sub> by Hugh D. Selby (2038372)

    Published 2005
    “…All three phases are semiconductors with optical band gaps of 2.95, 2.17, and 2.49 eV(<b>I</b>−<b>III</b>). Compound <b>I</b> crystallizes in the orthorhombic space group <i>Cmcm</i> with <i>a </i>= 4.076(1) Å, <i>b</i> = 13.864(4) Å, and <i>c</i> = 10.541(3) Å. …”
  5. 14005

    Increased GLB1 correlates with decreased proliferation and increased expression of HP1γ in benign tissue. by Jennifer Wagner (523883)

    Published 2015
    “…<p>The microarrays were immunostained for the proliferation protein Ki67, the heterochromatin protein HP1γ increased in senescence, and p27, a marker decreased in terminal senescence. Separating benign cores into high and low Ki67 and GLB1 staining, we found that the population of high GLB1-low Ki67 (box 4), representing the senescent population, expressed low p27 and high HP1γ as expected for senescent cells. …”
  6. 14006

    Advancing the science of NOWS research. by Sarah E. Maylott (14560785)

    Published 2024
    “…Approximately 50% of these newborns will develop Neonatal Opioid Withdrawal Syndrome (NOWS) within 5 days of birth. It is not known which infants will develop NOWS, therefore, the current hospital standard-of-care dictates a 96-hour observational hold. …”
  7. 14007

    Protocol measures. by Sarah E. Maylott (14560785)

    Published 2024
    “…Approximately 50% of these newborns will develop Neonatal Opioid Withdrawal Syndrome (NOWS) within 5 days of birth. It is not known which infants will develop NOWS, therefore, the current hospital standard-of-care dictates a 96-hour observational hold. …”
  8. 14008

    Cry variables. by Sarah E. Maylott (14560785)

    Published 2024
    “…Approximately 50% of these newborns will develop Neonatal Opioid Withdrawal Syndrome (NOWS) within 5 days of birth. It is not known which infants will develop NOWS, therefore, the current hospital standard-of-care dictates a 96-hour observational hold. …”
  9. 14009
  10. 14010
  11. 14011
  12. 14012
  13. 14013

    Treatment with anti-JAM-C antibody decreases neutrophil infiltration into the joints during antigen-induced arthritis by Gaby Palmer (636)

    Published 2011
    “…In the right panels, leukocyte infiltration per field was evaluated by semi-quantitative scoring for anti-JAM-C antibody-treated (= 6, black columns) and isotype-matched control antibody-treated (= 5, open columns) mice. There was a significant decrease in synovial neutrophil infiltration in anti-JAM-C antibody-treated mice as compared to isotype-matched antibody-treated controls. *< 0.05 versus control mice, as assessed by analysis of variance. …”
  14. 14014
  15. 14015
  16. 14016
  17. 14017
  18. 14018
  19. 14019
  20. 14020